Friday, 27 September 2013

United States Pharmaceuticals and Healthcare Report Q4 2013

Business Monitor International Market Research Reports
Market Reports Online XML Feed 
All Tech news in ONE place

Tired of browsing thru hundreds of RSS feeds? Try Techi. All the tech news from around the web in ONE place, including exclusive articles. Daily newsletter.
From our sponsors
United States Pharmaceuticals and Healthcare Report Q4 2013
Sep 25th 2013, 00:00

Price: $ 1295  

BMI View: Multinational drugmakers with higher exposure to the US pharmaceutical market will outperform rivals with established presences in Western Europe and emerging markets. The former region is under pressure from austerity-induced medicine price cuts, and many markets will experience significant contractions in 2013. Meanwhile, the latter is seeing currency weakness and deepening industry-specific challenges, such as the bribery/corruption scandal in China. The US remains highly attractive due to the willingness of payers to reimburse patients for high-value patented pharmaceuticals. Headline Expenditure Projections ? Pharmaceuticals: US$343.0bn in 2012 to US$342.6bn in 2013; -0.1% growth in local currency terms. Forecast slightly down from Q313 due to macroeconomic factors. ? He ...

Complete report details with Table of Contents and more @

Delicious Digg Evernote Facebook Google Bookmarks Google Plus LinkedIn StumbleUpon Tumblr Twitter
You are receiving this email because you subscribed to this feed at

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment